Published in Drug Week, January 6th, 2012
"This analysis begins with a survey of phosphate group and phosphoprotein properties which provide...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.